PEYE - PEYE STOCK NEWS

Precision Optics Corporation (OTCQB: PEYE) announced $2.5 million in production orders from a large medical device company for spinal surgery products using its proprietary illumination technology. The company has supplied this product for over a decade, with previous yearly run rates averaging $625,000 before a pandemic-related drop to $160,000 in 2021. With restrictions easing, Precision Optics expects to deliver approximately $1.2 million by the end of FY 2022 and $1.3 million in FY 2023, reflecting a recovery in elective surgeries.

Precision Optics Corporation (OTCQB: PEYE) has secured a $1.5 million production order from a prominent defense/aerospace company for a new optical application. The order follows nearly two years of collaboration to finalize specifications and successful prototype demonstrations. Initial shipments are expected in the current fiscal quarter, with more to follow over the next two quarters. The company anticipates this could lead to future orders, bolstering its long-term growth.

Precision Optics Corporation (OTCQB: PEYE) has scheduled a conference call for February 14, 2022, at 5:00 pm ET to discuss its second quarter financial results for fiscal year 2022. The financial results will be released and a 10-Q filing will occur after market close on the same day. Interested parties can join the call by dialing (844) 735-3662 or accessing a live webcast. A replay of the call will be available until February 21, 2022.

Precision Optics Corporation (OTCQB: PEYE) will participate in the Lytham Partners Winter 2021 Investor Conference from December 13-16, 2021. The company will host a webcasted Fireside Chat on December 13 at 11:00am ET, discussing its vision for 2022. Investors can watch the event on their website or through a provided link. Additionally, 1x1 virtual meetings with management can be arranged via Lytham Partners. The company focuses on advanced optical instruments for medical and defense industries, leveraging proprietary technologies for innovative solutions.

Precision Optics Corporation (OTCQB: PEYE) has reported its first quarter fiscal results for the period ending September 30, 2021. The company generated $2.34 million in revenue, down from $2.76 million a year ago, although production revenue of $1.96 million hit a four-quarter high. A net loss of $576,801 included acquisition-related expenses of $172,174. Despite this, the company has secured a subsequent production order worth $875,000 for its defense program, with expectations of improved financial performance moving forward.

Precision Optics Corporation (OTCQB: PEYE) has announced a conference call to discuss its first quarter of fiscal year 2022 financial results scheduled for November 15, 2021, at 5:00pm ET. The company will release its financial results and file its 10-Q after market close on the same day. Interested parties can join the call via telephone or access a live webcast. The replay will be available until November 22, 2021. Precision Optics specializes in micro-optics and 3D imaging technologies, serving healthcare and defense/aerospace industries.

Precision Optics Corporation (OTCQB: PEYE) announces its participation in the Lytham Partners Fall 2021 Investor Conference on October 7, 2021, at 4:15 PM ET. A webcast will also be available on the company’s website and archived for later access. The event includes virtual one-on-one meetings for investors. Established in 1982, Precision Optics specializes in advanced optical instruments for medical and defense sectors, focusing on innovative micro-optics and 3D imaging technologies.

Precision Optics Corporation (OTCQB: PEYE) has acquired Lighthouse Imaging LLC, enhancing its capabilities in medical optics and digital imaging. The $2.85 million cash transaction includes 2.5 million shares of Precision Optics. Lighthouse Imaging generated $4.5 million in revenue with a focus on engineering services. The merger is expected to facilitate growth, with several projects transitioning from engineering to production within the year. Precision Optics anticipates that the acquisition will boost its profitability per share and strengthen its market presence in healthcare and defense.

Precision Optics Corporation (OTCQB: PEYE) reported a robust performance for the fourth quarter and fiscal year ending June 30, 2021. Q4 revenue grew to $2.67 million, up 19% from last year. Total fiscal year revenue reached a record $10.67 million, an increase from $9.92 million in FY 2020. However, net loss for Q4 was $442,443, higher than $323,085 in the previous year, largely due to stock-based compensation. The company maintained a solid cash position of $862,000 as of year-end, with operating expenses down 9% year-over-year.